Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Re-sequencing of CA-MHB adapted endpoint clones Staphylococcus aureus

PROVIDER: PRJNA579343 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10341521_1.fastq.gz	Fastqsanger.gz
	SRR10341521_2.fastq.gz	Fastqsanger.gz
	SRR10341522_1.fastq.gz	Fastqsanger.gz
	SRR10341522_2.fastq.gz	Fastqsanger.gz
	SRR10341523_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Profiling the effect of Nafcillin on HA-MRSA D712 using bacteriological and physiological media

Project description:Vancomycin Intermediate Staphylococcus aureus (VISA) strain originated during the prolonged hospitalization, chronic infection and vancomycin treatment. The hospital acquired D712 VISA strain were subjected to various sub-inhibitory concentration of nafcillin in Cation Adjusted Mueller Hinton Broth (CA-MHB) and Roswell Park Memorial Institute (RPMI) medium. The MIC of has dropped from 256 ug/ml to 1ug/ml in CA-MHB and RPMI media respectively. The cells were harvested and expression profiling were measured using RNA sequencing at time point of 03 hours.

2019-10-22 | GSE139141 | GEO

U01_Staphylococcus_Aureus_USA300_Orbitrap_Tandem_MS

Project description:LC-MS/MS data for exometabolomic analysis of Staphylococcus aureus grown in RPMI+10%LB and CA-MHB growth media in the presence & absence of antibiotic (nafcillin).

2019-05-13 | MSV000083766 | MassIVE

U01 ReDU-MS2 Staphylococcus_Aureus_USA300_Orbitrap_Tandem_MS

Project description:LC-MS/MS data for exometabolomic analysis of Staphylococcus aureus grown in RPMI+10%LB and CA-MHB growth media in the presence & absence of antibiotic (nafcillin).

2019-05-13 | MSV000083773 | MassIVE

Staphylococcus aureus TCH1516 LC/MS, HPLC, BPC data

Project description:This is a repository of LC/MS, HPLC, BPC data collected from Staphylococcus aureus TCH1516 grown in RPMI (+10%LB) and CA-MHB. Stains were treated with nafcillin.

2018-08-08 | MSV000082803 | MassIVE

Staphylococcus aureus TCH1516 LC/MS, HPLC, BPC data

Project description:This is a repository of LC/MS, HPLC, BPC data collected from Staphylococcus aureus TCH1516 grown in RPMI (+10%LB) and CA-MHB. Stains were treated with nafcillin.

2018-08-08 | MSV000082804 | MassIVE

Staphylococcus aureus D712 LC/MS, HPLC, BPC data

Project description:This is a repository of LC/MS, HPLC, BPC data collected from Staphylococcus aureus D712 grown in RPMI (+10%LB) and CA-MHB. Stains were treated with various concentrations of nafcillin.

2019-07-01 | MSV000084027 | MassIVE

Staphylococcus aureus D712 LC/MS, HPLC, BPC data

2019-06-17 | MSV000083981 | MassIVE

GNPS_UCSD_U01_iARM_Set01_COM01_CA-MHB_Metabolomics_Untargeted_RP-C18

Project description:UCSD U01 iARM Set 01 COM 01. Staphylococcus aureus in CA-MHB media. Untargeted RP-C18 HRLC-MS/MS.

2017-04-10 | MSV000080898 | GNPS

Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies

Project description:Background: Telavancin is a novel semi-synthetic lipoglycopeptide derivative of vancomycin with a decylaminoethyl side chain that is active against Gram-positive bacteria including Staphylococcus aureus strains resistant to methicillin or vancomycin. This study describes transcriptome alterations in S. aureus strain ATCC29213 treated with telavancin for 15 min and 60 min in comparing with other agents treatment, including vancomycin, enduracidin, m-chlorophenylhydrazone. MHB cultures (biological replicates: N=3) were then grown to exponential phase (OD580=0.35) before the addition of telavancin(8 M-BM-5g/ml final concentration), or vancomycin (10 /M-BM-5g ml) or CCCP (2 M-BM-5g/ ml ); or enduracidin (1 M-BM-5g ml) and incubated for an additional 15 min , and 60 min before sampling. Dye-swapping was performed between samples.

2012-04-13 | E-GEOD-37272 | biostudies-arrayexpress

GNPS_UCSD_U01_iARM_Set01_COM02_CA-MHB_Metabolomics_Targeted_HILIC_Amide

Project description:UCSD U01 iARM Set 01 COM 02. Staphylococcus aureus in CA-MHB media. Targeted small molecule HILIC-Amide HRLC-MS/MS.

2017-04-10 | MSV000080902 | GNPS